Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01351311
Other study ID # FDAAAMC
Secondary ID
Status Completed
Phase N/A
First received May 9, 2011
Last updated November 29, 2012
Start date March 2011
Est. completion date November 2012

Study information

Verified date November 2012
Source Federal University of São Paulo
Contact n/a
Is FDA regulated No
Health authority Brazil: Ethics Committee
Study type Interventional

Clinical Trial Summary

The aim of the present study is to assess the effectiveness of resistance training with swiss ball in the treatment of patients with ankylosing spondylitis.


Description:

A randomized, controlled, single-blind, prospective trial being conducted involving 54 patients with ankylosing spondylitis, selected from outpatient clinics - UNIFESP. They will be randomized in intervention group (n = 27) conduct training for muscle strengthening with the aid of the Swiss ball and in the control group (n = 27) did not undergo any intervention. Eight exercises will be conducted with intent to engage all muscle groups.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date November 2012
Est. primary completion date November 2012
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

- Patients with established diagnosis of AS steinbrocker functional class I-II

- Basic medication stable for at least three months

- Agreed to participate and signed term of informed consent

Exclusion Criteria:

- Uncontrolled hypertension

- Coronary artery disease

- History of revascularization

- History of syncope or arrhythmias induced by exercise

- Decompensated diabetes mellitus

- Severe psychiatric illness

- Fibromyalgia

- Another medical condition more disabling than AS

- History of exercise regular (at least 30 minutes 2 times per week)

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Intervention

Other:
Exercise
Resistance Training exercise with swiss ball
Drug treatment
Drug treatment

Locations

Country Name City State
Brazil Marcelo Cardoso de Souza Sao Paulo

Sponsors (2)

Lead Sponsor Collaborator
Federal University of São Paulo Fundação de Amparo à Pesquisa do Estado de São Paulo

Country where clinical trial is conducted

Brazil, 

References & Publications (1)

American College of Sports Medicine. American College of Sports Medicine position stand. Progression models in resistance training for healthy adults. Med Sci Sports Exerc. 2009 Mar;41(3):687-708. doi: 10.1249/MSS.0b013e3181915670. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Bath Ankylosing Spondylitis Functional Index (BASFI) Functional capacity assessed by BASFI 16 weeks Yes
Secondary LIKERT SCALE Likert scale by patients. 16 weeks Yes
Secondary 1 REPETITION MAXIMUM TEST muscle strength by testing an repetition maximum (1 RM) 16 weeks Yes
Secondary Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) disease activity by BASDAI (The Bath Ankylosing Spondylitis Disease Activity Index) 16 weeks Yes
Secondary Bath Ankylosing Spondylitis Metrology Index (BASMI) spinal mobility by BASMI 16 weeks Yes
Secondary erythrocyte sedimentation rate (ESR) 16 weeks Yes
Secondary 6-MINUTE WALK TEST 16 weeks Yes
Secondary TIME UP AND GO TEST 16 weeks Yes
Secondary Short form-36 (SF-36) quality of life by SF-36 16 weeks No
Secondary QUANTITY OF ANALGESICS AND ANTI-INFLAMATORY USED 16 weeks Yes
Secondary Health Assessment Questionnaire (HAQ) Health Assessment Questionnaire Function 16 weeks No
See also
  Status Clinical Trial Phase
Terminated NCT02685904 - A Multicentre Study to Evaluate the Efficacy and Safety of ENIA11 in Patients With Ankylosing Spondylitis Phase 3
Completed NCT02186873 - A Study of Golimumab in Participants With Active Ankylosing Spondylitis Phase 3
Completed NCT01668004 - The Incidence of Extra-Articular Manifestations in Participants With Ankylosing Spondylitis Treated With Golimumab (MK-8259-012) Phase 4
Completed NCT05051943 - A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
Completed NCT01934933 - Etanercept and Celecoxib Alone/Combined Treatment in Effectiveness and Safety of Active Ankylosing Spondylitis Phase 4
Not yet recruiting NCT04875299 - Optimal Adalimumab Plasma Concentrations in Ankylosing Spondylitis Patients
Completed NCT02763111 - Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of Various Doses of BCD-085 in Patients With Active Ankylosing Spondylitis Phase 2
Completed NCT02758782 - NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy Alone on Progression of Structural Damage in Ankylosing Spondylitis Phase 4
Active, not recruiting NCT02687620 - Does Immunogenicity Have an Influence on the Efficacy of Anti-TNF Therapy in Patients With AS: An Inception Cohort Study
Completed NCT02154425 - A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers Phase 1
Completed NCT01750528 - Prevalence and Progression of Periodontitis in Ankylosing Spondylitis N/A
Completed NCT01463189 - Web-based Support to Manage Arthritis Pain Phase 2
Completed NCT01091675 - Assessment of the Response to Etoricoxib in Patients With Ankylosing Spondylitis and Inadequate Response to ≥2 NSAIDs Phase 3
Completed NCT00844805 - Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1) Phase 3
Recruiting NCT00747578 - Health-Related Quality of Life and Disease-Related Costs: Comparison Between Ankylosing Spondylitis, Rheumatoid Arthritis and Systemic Lupus Erythematosus in Taiwan N/A
Completed NCT00715091 - Effects of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) on RAdiographic Damage in Ankylosing Spondylitis Phase 4
Completed NCT01083693 - Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS) After Unsustainable Response to Biologicals and Disease Modifying Antirheumatic Drugs N/A
Not yet recruiting NCT00517101 - Presence of IBD Specific Antibodies (ASCA, ALCA, ACCA, AMCA) in the Sera of Patients With Spondyloarthropathy N/A
Completed NCT00367211 - Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated Ulcers. Phase 3
Completed NCT00133315 - TNFalfa Blocking Treatment of Spondylarthropathies Phase 4